Curis, Inc. to Present at 7th Annual Biotechnology Industry Organization (BIO) Investor Forum Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing the next generation of proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the 7th Annual BIO Investor Forum Conference, at 3:45 p.m. local time (6:45 p.m. EDT) on October 30, 2008, at the Palace Hotel in San Francisco, California.
MORE ON THIS TOPIC